Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1959 1
1990 1
1991 1
1993 1
1994 4
1996 2
1997 1
1998 1
1999 3
2000 5
2001 1
2004 3
2005 1
2007 2
2008 7
2009 10
2010 8
2011 11
2012 11
2013 12
2014 15
2015 21
2016 16
2017 22
2018 24
2019 20
2020 23
2021 28
2022 29
2023 23
2024 23
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

299 results

Results by year

Filters applied: . Clear all
Page 1
Challenges in neoantigen-directed therapeutics.
Lybaert L, Lefever S, Fant B, Smits E, De Geest B, Breckpot K, Dirix L, Feldman SA, van Criekinge W, Thielemans K, van der Burg SH, Ott PA, Bogaert C. Lybaert L, et al. Among authors: smits e. Cancer Cell. 2023 Jan 9;41(1):15-40. doi: 10.1016/j.ccell.2022.10.013. Epub 2022 Nov 10. Cancer Cell. 2023. PMID: 36368320 Free article. Review.
The CD70-CD27 axis in oncology: the new kids on the block.
Flieswasser T, Van den Eynde A, Van Audenaerde J, De Waele J, Lardon F, Riether C, de Haard H, Smits E, Pauwels P, Jacobs J. Flieswasser T, et al. Among authors: smits e. J Exp Clin Cancer Res. 2022 Jan 6;41(1):12. doi: 10.1186/s13046-021-02215-y. J Exp Clin Cancer Res. 2022. PMID: 34991665 Free PMC article. Review.
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
Van den Eynde A, Gehrcken L, Verhezen T, Lau HW, Hermans C, Lambrechts H, Flieswasser T, Quatannens D, Roex G, Zwaenepoel K, Marcq E, Joye P, Cardenas De La Hoz E, Deben C, Gasparini A, Montay-Gruel P, Le Compte M, Lion E, Lardon F, Van Laere S, Siozopoulou V, Campillo-Davo D, De Waele J, Pauwels P, Jacobs J, Smits E, Van Audenaerde JRM. Van den Eynde A, et al. Among authors: smits e. J Hematol Oncol. 2024 Feb 9;17(1):8. doi: 10.1186/s13045-024-01525-w. J Hematol Oncol. 2024. PMID: 38331849 Free PMC article.
Trial watch: chemotherapy-induced immunogenic cell death in oncology.
Sprooten J, Laureano RS, Vanmeerbeek I, Govaerts J, Naulaerts S, Borras DM, Kinget L, Fucíková J, Špíšek R, Jelínková LP, Kepp O, Kroemer G, Krysko DV, Coosemans A, Vaes RDW, De Ruysscher D, De Vleeschouwer S, Wauters E, Smits E, Tejpar S, Beuselinck B, Hatse S, Wildiers H, Clement PM, Vandenabeele P, Zitvogel L, Garg AD. Sprooten J, et al. Among authors: smits e. Oncoimmunology. 2023 Jun 3;12(1):2219591. doi: 10.1080/2162402X.2023.2219591. eCollection 2023. Oncoimmunology. 2023. PMID: 37284695 Free PMC article. Review.
Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.
Rovers S, Van Audenaerde J, Verloy R, De Waele J, Brants L, Hermans C, Lau HW, Merlin C, Möller Ribas M, Ponsaerts P, Van Laere S, Lardon F, Wouters A, Fisher SA, van Meerbeeck J, Marcq E, Smits E. Rovers S, et al. Among authors: smits e. Oncoimmunology. 2025 Dec;14(1):2512104. doi: 10.1080/2162402X.2025.2512104. Epub 2025 May 29. Oncoimmunology. 2025. PMID: 40439143 Free PMC article.
Human organoids and organ-on-chips in coeliac disease research.
Simpson HL, Smits E, Moerkens R, Wijmenga C, Mooiweer J, Jonkers IH, Withoff S. Simpson HL, et al. Among authors: smits e. Trends Mol Med. 2025 Feb;31(2):117-137. doi: 10.1016/j.molmed.2024.10.003. Epub 2024 Oct 23. Trends Mol Med. 2025. PMID: 39448329 Free article. Review.
Targeting hedgehog signaling in pancreatic ductal adenocarcinoma.
Quatannens D, Verhoeven Y, Van Dam P, Lardon F, Prenen H, Roeyen G, Peeters M, Smits ELJ, Van Audenaerde J. Quatannens D, et al. Among authors: smits elj. Pharmacol Ther. 2022 Aug;236:108107. doi: 10.1016/j.pharmthera.2022.108107. Epub 2022 Jan 7. Pharmacol Ther. 2022. PMID: 34999181 Review.
Lack of functional TCR-epitope interaction is associated with herpes zoster through reduced downstream T cell activation.
Boeren M, de Vrij N, Ha MK, Valkiers S, Souquette A, Gielis S, Kuznetsova M, Schippers J, Bartholomeus E, Van den Bergh J, Michels N, Aerts O, Leysen J, Bervoets A, Lambert J, Leuridan E, Wens J, Peeters K, Emonds MP, Elias G, Vandamme N, Jansens H, Adriaensen W, Suls A, Vanhee S, Hens N, Smits E, Van Damme P, Thomas PG, Beutels P, Ponsaerts P, Van Tendeloo V, Delputte P, Laukens K, Meysman P, Ogunjimi B. Boeren M, et al. Among authors: smits e. Cell Rep. 2024 Apr 23;43(4):114062. doi: 10.1016/j.celrep.2024.114062. Epub 2024 Apr 7. Cell Rep. 2024. PMID: 38588339 Free article.
299 results